← Browse by Condition
Medical Condition

chronic obstructive pulmonary disease

Total Trials
17
Recruiting Now
17
Trial Phases
Phase 4, Phase 2, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for chronic obstructive pulmonary disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — chronic obstructive pulmonary disease Clinical Trials

How many clinical trials are currently recruiting for chronic obstructive pulmonary disease?
ClinicalMetric currently tracks 17 actively recruiting clinical trials for chronic obstructive pulmonary disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 17. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for chronic obstructive pulmonary disease?
chronic obstructive pulmonary disease research spans Phase 1 (2 trials), Phase 2 (3 trials), Phase 3 (2 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a chronic obstructive pulmonary disease clinical trial?
Eligibility criteria for chronic obstructive pulmonary disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Phase 2
3
Phase 3
2
Phase 4
1
Top Sponsors
University Hospital, Grenoble 2 trials
Sanofi 2 trials
Clinact 1 trial
University Health Network, Toronto 1 trial
Icahn School of Medicine at Mount Sinai 1 trial

Recruiting Clinical Trials

NCT03890224
Recruiting
Respiratory Support in Chronic Obstructive Pulmonary Disease (COPD) Patients
Enrollment
400 pts
Location
France
Sponsor
Clinact
View Trial →
NCT06253013
Recruiting
CHARM-COPD Program of Care
Enrollment
100 pts
Location
Canada
Sponsor
University Health Network, Tor...
View Trial →
NCT06634810
Recruiting
Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-management
Enrollment
300 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo...
View Trial →
NCT05772013 Phase 4
Recruiting
Optimising Azithromycin Prevention Treatment in COPD to Reduce Exacerbations
Enrollment
1,311 pts
Location
United Kingdom
Sponsor
Dr Ian B Wilkinson
View Trial →
NCT06326957
Recruiting
Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREATHE)
Enrollment
246 pts
Location
United Kingdom
Sponsor
King's College Hospital NHS Tr...
View Trial →
NCT00307281
Recruiting
Emphysema Research Registry and Biosample Repository
Enrollment
3,000 pts
Location
United States
Sponsor
University of Pittsburgh
View Trial →
NCT07418736 Phase 2
Recruiting
A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Enrollment
318 pts
Location
China
Sponsor
CSPC ZhongQi Pharmaceutical Te...
View Trial →
NCT04427826 Phase 1, Phase 2
Recruiting
Efficacy of Morphine in Reducing the Rate of Early Non-Invasive Ventilation Failure in Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Phase I/IIa
Enrollment
24 pts
Location
France
Sponsor
University Hospital, Grenoble
View Trial →
NCT06756646
Recruiting
Exploring the Effects of Aerobic Exercise Combined with BFRT on Patients with COPD
Enrollment
90 pts
Location
Taiwan
Sponsor
National Cheng Kung University
View Trial →
NCT06068647
Recruiting
Ultrasound and Respiratory Physiological Signals in Lung Diseases
Enrollment
25 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
View Trial →
NCT06163131
Recruiting
The Effect of Treatment of Emphysema With Endobronchial Valves on the Diaphragm Mobility
Enrollment
35 pts
Location
Denmark
Sponsor
Aarhus University Hospital
View Trial →
NCT07190209 Phase 3
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Enrollment
942 pts
Location
United States, Argen...
Sponsor
Sanofi
View Trial →
NCT07384897
Recruiting
Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease
Enrollment
425 pts
Location
Belgium
Sponsor
Université Catholique de Louva...
View Trial →
NCT03014609
Recruiting
Cardiovascular Risk and Chronic Obstructive Pulmonary Disease
Enrollment
150 pts
Location
France
Sponsor
University Hospital, Grenoble
View Trial →
NCT03799354
Recruiting
Study on Impact of Maximal Strength Training in Patients With COPD
Enrollment
20 pts
Location
Italy
Sponsor
Istituti Clinici Scientifici M...
View Trial →
NCT05746039 Phase 1, Phase 2
Recruiting
Feasibility of Semaglutide in Advanced Lung Disease
Enrollment
8 pts
Location
United States
Sponsor
University of Pennsylvania
View Trial →
NCT07190222 Phase 3
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Enrollment
942 pts
Location
United States, Argen...
Sponsor
Sanofi
View Trial →

Related Conditions

interstitial lung disease (3) emphysema or copd (2) copd exacerbation (1) bronchiectasis (1) lung cancer (1) asthma (1) dyspnea (1) fibrotic lung disease (1) chronic lung disease (1) emphysema (1) chronic bronchitis (1) interstitial lung diseases (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology